Wang Jing, Shen Yun, Zhang Yiming, Zhang Rui, Tang Xiaoshan, Fang Li, Xu Yuanzhi
Department of Stomatology, Shanghai Tenth People's Hospital Tongji University School of Medicine, No. 301., Middle Yanchang Road Shanghai 200072, P.R. China.
Curr Stem Cell Res Ther. 2016;11(3):188-96. doi: 10.2174/1574888x10666150416113630.
In recent years, beneficial effects of various ligands of three peroxisome-proliferator-activated receptor (PPAR) isoforms (α, β, γ) have been reported in neurodegenerative diseases through delaying the onset and progression of diseases, reducing lesion size and improving functional recovery. Neural stem cells (NSCs) are assumed as a promising strategy for the treatment of human neurodegenerative diseases. PPARs are supposed to be one group of the key regulators of fate decisions in neural stem cells during development and adulthood, through their impact on the target genes involving cell proliferation, death and differentiation. The neuroprotective role of PPARs is suggested to be closely associated with the inflammation control and regenerative function of NSCs. Nevertheless, the molecular mechanisms remain to be elucidated. Here, we review the current knowledge about the beneficial role of PPARs in NSC development and neurogenesis and attempt to discuss the underlying mechanisms.
近年来,已报道三种过氧化物酶体增殖物激活受体(PPAR)亚型(α、β、γ)的各种配体通过延缓神经退行性疾病的发病和进展、减小病变大小及改善功能恢复,在神经退行性疾病中具有有益作用。神经干细胞(NSC)被认为是治疗人类神经退行性疾病的一种有前景的策略。PPARs被认为是神经干细胞在发育和成年期命运决定的一组关键调节因子,通过它们对涉及细胞增殖、死亡和分化的靶基因的影响。PPARs的神经保护作用被认为与神经干细胞的炎症控制和再生功能密切相关。然而,其分子机制仍有待阐明。在此,我们综述了关于PPARs在神经干细胞发育和神经发生中的有益作用的现有知识,并试图讨论其潜在机制。